1
Q
N=?
A
58 patients all Inotrope dependent
2
Q
Study design
A
Retrospective evaluation of 58 pts. at 3 centers (Baylor, Tufts & Univ. of Chicago) with decompensated HF refractory to medical therapy.
-Use of Impella 5.0 as Bridge to Decision in decompensated advances HF pts.
3
Q
Mean duration of support
A
7 days (0-22 days)
4
Q
Median age
A
59 years old
5
Q
% of patients surviving to next therapy
A
67% n=39/58
Durable MCS=20
Transplant=15
Weaned=4
6
Q
Complications Bleeding= Infection = Hemolysis = Stroke= Vascular injury req. surgery= Valve injury=
A
Bleeding= 16% Infection = 19% Hemolysis = 7% Stroke= 0% Vascular injury req. surgery= 2% Valve injury= 2%
Cardiogenic Shock
flashcards
Decks in class (6)
# Cards
